News-Medical.Net on MSN
Combination therapy offers hope for ending lifelong chronic lymphocytic leukemia treatment
Ianalumab targets the B-cell activating factor receptor (BAFR) and ibrutinib belongs to a class of therapeutics called Bruton ...
1 Centre for Translational Neuroscience and Mental Health, School of Medicine and Public Health, University of Newcastle, Callaghan, New South Wales, Australia 2 Department of Physical Medicine and ...
Abstract: Evaluating the long-term influence of academic papers in the early stage after publication is crucial for research management and decision-making. Although the total number of citations has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback